Granules India Share Price Analyzed
Granules India’s stock jumped to a new high of ₹626.85 on Wednesday. This is a big deal because it’s the best price the stock has reached in the last year. The price went up 2% and beat its previous high of ₹621.10.
Key Points
- Granules India’s stock rose 2% to ₹626.85.
- Stock performance: 18% rise in last month.
- Funds raised: ₹1462.5 crore through warrants and ₹300 crore through shares.
- Dilution: Equity could decrease by 11% in the short term.
- Expansion plans: Focus on Oncology and GLP-1 peptide segments.
- Broker Views: ICICI Securities & Choice Institutional Equities maintain positive outlook.
The company is raising a lot of money – about ₹1462.5 billion and another ₹300 billion. They are doing this by selling special shares to the people who started Granules India and other investors. This extra money will help them grow.
Some experts think this is a good move. ICICI Securities believes the company wants to build bigger factories and focus on new medicines. They also think it might make the stock’s price go down a little bit in the short term, but it could become more valuable over time.
Choice Institutional Equities also likes Granules India, because they’re doing a good job and building new things. They expect the company to make more money in the future as they start making new medicines and providing services to other companies.
Because of all of this, the analysts at ICICI Securities and Choice Institutional Equities have raised their price target for Granules India’s stock. They think the stock could go even higher, possibly reaching ₹660 in the next few years.
Investing in companies that are growing and planning for the future is often a smart choice.
